bioAffinity Technologies, Inc. Financial Flexibility Index
bioAffinity Technologies, Inc. financial flexibility index. bioAffinity Technologies, Inc. (BIAF) has a Financial Flexibility Index of -0.68x as of December 2025. Free cash flow of $-2.50 Million (operating CF $-2.56 Million minus capex $60.56K) represents -1% of total liabilities ($3.68 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of bioAffinity Technologies, Inc. (2019–2025)
Financial flexibility index of bioAffinity Technologies, Inc. from 2019 to 2025. Historical Financial Flexibility Index trend for bioAffinity Technologies, Inc. across 7 annual periods. Check cash flow quality index of bioAffinity Technologies, Inc. to evaluate the quality of earnings relative to operating cash generation.
bioAffinity Technologies, Inc. Financial Flexibility Index by Year (2019–2025)
bioAffinity Technologies, Inc. financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for bioAffinity Technologies, Inc.. For the full cash flow conversion analysis, see cash efficiency ratio of bioAffinity Technologies, Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.52x | $-9.27 Million | $-9.33 Million | $3.68 Million | ▼ -37.0% |
| 2024 | -1.84x | $-7.19 Million | $-7.26 Million | $3.91 Million | ▼ -2.8% |
| 2023 | -1.79x | $-6.01 Million | $-6.04 Million | $3.37 Million | ▲ +47.2% |
| 2022 | -3.38x | $-3.85 Million | $-4.07 Million | $1.14 Million | ▼ -2746.1% |
| 2021 | -0.12x | $-2.05 Million | $-2.05 Million | $17.24 Million | ▲ +18.0% |
| 2020 | -0.14x | $-2.20 Million | $-2.21 Million | $15.22 Million | ▲ +72.6% |
| 2019 | -0.53x | $-2.48 Million | $-2.49 Million | $4.69 Million | — |